Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    New updates have been added, including a completion date of 2024-12-20 and an actual date of 2024-12-12, while previous entries such as 'Active, not recruiting' and several estimated dates have been removed.
    Difference
    0.7%
    Check dated 2024-12-21T23:09:29.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:33:14.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, replacing the previous information with new details and revising the certification dates.
    Difference
    3%
    Check dated 2024-12-07T15:55:02.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    AbbVie has added new information regarding the IMGN853-0419 study, including a study director and helpful links, while ImmunoGen, Inc. has been removed from the list.
    Difference
    1%
    Check dated 2024-11-30T12:32:55.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    3%
    Check dated 2024-11-23T04:32:20.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.
    Difference
    3%
    Check dated 2024-11-15T23:28:08.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.